XRAY
Dentsply Sirona Inc
Dentsply Sirona Inc historical holders
total: 8
Viking Global Investors Dentsply Sirona Inc transactions over time
- Total transactions:
- 12
- New positions:
- 2
- Sold out:
- 2
- Added:
- 6
- Reduced:
- 2
- Held since:
- 2016 Q3
- Held for:
- 8 quarters
- Latest activity:
- 2018 Q3
Ole Andreas Halvorsen has been an institutional investor in Dentsply Sirona Inc (XRAY) since 2015 Q3. According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any shares. The fund/company first acquired XRAY in 2015 Q3, initially purchasing 50,000 shares. Ole Andreas Halvorsen later completely sold out the position and reinvested in XRAY again in 2016 Q3. Since the initial investment, Viking Global Investors has made 11 more transactions in this position.
When did Ole Andreas Halvorsen exit their XRAY position?
Ole Andreas Halvorsen no longer holds Dentsply Sirona Inc (XRAY). They sold off their entire position in 2018 Q3, closing out an investment that began in 2015 Q3.
When did Ole Andreas Halvorsen first invest in XRAY?
Ole Andreas Halvorsen first invested in Dentsply Sirona Inc (XRAY) in 2015 Q3 at the reported quarter-end price of $50.58 per share, acquiring 50,000 shares in their initial purchase.
What is Ole Andreas Halvorsen's average cost basis for XRAY?
Based on historical transaction data, Ole Andreas Halvorsen's estimated cost basis for Dentsply Sirona Inc (XRAY) is approximately $57.34 per share. This represents their average reported price* across all buy transactions.
Has Ole Andreas Halvorsen reinvested in XRAY after selling?
Yes, Ole Andreas Halvorsen has shown renewed interest in Dentsply Sirona Inc (XRAY). After completely selling their position, they reinitiated an investment in 2016 Q3, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $57.34
- Weighted AVG sell price:
- $45.30
XRAY transactions history by Viking Global Investors
12 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2018 Q3
|
0.00%
|
$43.77
|
-100% (-984,025)
|
|||
|
2018 Q2
|
0.25%
|
$43.77
|
-89.35% (-8,257,198)
|
|||
|
2018 Q1
|
2.80%
|
$50.31
|
+71.21% (+3,843,516)
|
|||
|
2017 Q4
|
2.18%
|
$65.83
|
+51.90% (+1,844,190)
|
|||
|
2017 Q3
|
1.38%
|
$59.81
|
+148.43% (+2,123,148)
|
|||
|
2017 Q2
|
0.62%
|
$64.84
|
+67.41% (+575,971)
|
|||
|
2017 Q1
|
0.24%
|
$62.44
|
-49.15% (-825,756)
|
|||
|
2016 Q4
|
0.44%
|
$57.73
|
+141.89% (+985,547)
|
|||
|
2016 Q3
|
0.18%
|
$59.43
|
new
|
|||
|
2016 Q1
|
0.00%
|
$60.85
|
-100% (-1,035,264)
|
|||
|
2015 Q4
|
0.24%
|
$60.85
|
+1,970.53% (+985,264)
|
|||
|
2015 Q3
|
0.01%
|
$50.58
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.